TCI receives six (6) additional Certificates of Analyses for commonly prescribed antidiabetic medicine

Press Release 

 From the ministry of health and human services

Providenciales, Turks and Caicos Islands, 24 June 2025 – The Pharmacy Unit within the Ministry of Health and Human Services (MoHHS) is pleased to report that it has received six (6) additional certificates of analyses following the testing and analyses of six (6) samples of the commonly prescribed antidiabetic medicine, metformin. This brings to a total of 11 samples following the receipt of five (5) certificates of analyses earlier this year. The samples – which have been confirmed as achieving the required quality standard – were selected from batches that have been utilised on the Turks and Caicos Islands (TCI) market.

A Certificate of Analysis is a legal document that certifies the quality of a medicine and/or its ingredients known as excipients. The certificate demonstrates that the batch/ sample tested meets all the required quality control standards which confirms product quality and safety.

The Unit continues to partner with the Medicines Quality Control and Surveillance Department (MQCSD) of the Caribbean Public Health Agency (CARPHA) as a part of their risk-based Post-Market Surveillance (PMS) Programme for medicines to conduct these tests and analyses. The TCI’s involvement in the PMS Programme continues to strengthen and support the effectiveness of its medicines regulatory system by:

• Providing data and information that will better inform the government on the appropriate and effective regulatory actions and strategies to implement (that will improve the availability of safe and essential good quality medicines), and
• Identifying in a timely manner, possible substandard and falsified products/medicines on the TCI market.

Importantly, the Minister of Health and Human Services – Honourable Kyle R. Knowles declared that “it is essential to improve fair access to safe, effective and quality medicines as these are hallmarks of effective disease management/treatment.” As such Hon. Knowles notes that “the MoHHS and by extension, the Pharmacy Unit, will continue to strengthen the systems and capacities required to improve the effective monitoring of drug/patient safety.”

The MoHHS will continue to ensure that the health and wellbeing of all TCI residents are positively impacted by actively monitoring and regulating all medicines used within the TCI. The MoHHS is also encouraging persons to utilise the Adverse Drug Reaction Form – found at https://gov.tc/docs/ADR.pdf – to report any suspected:

• adverse events – suffered from the use of medicines and/or
• substandard or falsified medicines.

These reports are paramount as they aid in determining whether medicines will be submitted for analysis and testing.

For further information, please contact André Morgan, National Pharmacist at: (649)338-3072 or amorgan@gov.tc and visit the Ministry of Health’s Facebook page on https://www.facebook.com/tciministryofhealth.